Jamieson is pleased to announce that is has advised the management team of Calyx on their acquisition from Pamplona to GLO Healthcare, a business backed by CapVest Partners.
Headquartered in the UK and US, Calyx develops clinical technology-based products and services for companies to facilitate clinical drug development.
Stephen Maxwell and Adam Colley from Jamieson’s London office worked alongside Jamieson’s New York office to advise the transatlantic management team on the transaction.
